Filip Matthijssens
Gent, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Effect of efgartigimod IV on immature platelet fraction in primary immune thrombocytopenia in the ADVANCE IV trial.
Journal: British journal of haematology
Published: June 10, 2026
Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 Trial.
Journal: American journal of hematology
Published: March 09, 2026
A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemia.
Journal: Science advances
Published: November 01, 2024
CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia.
Journal: Haematologica
Published: February 10, 2023
Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia.
Journal: Blood cancer discovery
Published: November 12, 2020
Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice.
Journal: The Journal of experimental medicine
Published: October 24, 2020
Alternative glycosylation controls endoplasmic reticulum dynamics and tubular extension in mammalian cells.
Journal: Science advances
Published: September 27, 2020
PHF6 Expression Levels Impact Human Hematopoietic Stem Cell Differentiation.
Journal: Frontiers in cell and developmental biology
Published: August 27, 2020
RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia.
Journal: The Journal of clinical investigation
Published: June 22, 2020
Last Updated: 09/26/2026